COVID-19 symptoms are reduced by targeted hydration of the nose, larynx and trachea.

COVID-19 symptoms are reduced by targeted hydration of the nose, larynx and trachea.
复制标题

通过对鼻、喉和气管进行有针对性的水合作用,可减轻COVID-19症状。

DOI:
10.1038/s41598-022-08609-y
复制
发表时间:
2022-03-29
期刊:
影响因子:
4.6
通讯作者:
Edwards DA
Edwards DA
中科院分区:
综合性期刊3区
文献类型:
--
作者:
George CE;Scheuch G;Seifart U;Inbaraj LR;Chandrasingh S;Nair IK;Hickey AJ;Barer MR;Fletcher E;Field RD;Salzman J;Moelis N;Ausiello D;Edwards DA

文献摘要

参考文献

被引文献

相似文献

上呼吸道的脱水会增加呼吸道疾病的风险,从COVID-19到哮喘和COPD。我们在涉及德国、美国和印度464名人类受试者的人类志愿者研究中发现,在老年(n = 357)、BMI升高(n = 148)、剧烈运动(n = 20)和SARS-CoV-2感染(n = 87)的脱水相关状态下,呼吸液滴生成增加多达4个数量级,而福尔斯则因鼻子水合而跌倒,喉和气管的高渗盐。我们还发现,在运动诱导的气道脱水的方案中,通过富含钙的盐的气道水合作用相对于未治疗的对照增加了氧合(P <0.05)。在一项针对COVID-19阳性受试者(n = 40)的随机对照研究中,每天三次给予富钙高渗盐(活性)抑制了51% ± 11%的呼吸液滴生成,并在治疗三天内将氧饱和度提高了48.08% ± 9.61%(P <0.001),而鼻盐水对照组没有观察到变化。活动组的自我报告症状显著下降,而对照组没有下降。上呼吸道的水合作用似乎很有希望成为降低COVID-19等呼吸道疾病风险的非药物方法。
Dehydration of the upper airways increases risks of respiratory diseases from COVID-19 to asthma and COPD. We find in human volunteer studies involving 464 human subjects in Germany, the US, and India that respiratory droplet generation increases by up to 4 orders of magnitude in dehydration-associated states of advanced age (n = 357), elevated BMI-age (n = 148), strenuous exercise (n = 20) and SARS-CoV-2 infection (n = 87), and falls with hydration of the nose, larynx and trachea by calcium-rich hypertonic salts. We also find in a protocol of exercise-induced airway dehydration that hydration of the airways by calcium-rich salts increases oxygenation relative to a non-treatment control (P < 0.05). In a random control study of COVID-19 positive subjects (n = 40), thrice-a-day delivery of the calcium-rich hypertonic salts (active) suppressed respiratory droplet generation by 51% ± 11% and increased oxygen saturation over three days of treatment by 48.08% ± 9.61% (P < 0.001), while no changes were observed in the nasal-saline control group. Self-reported symptoms significantly declined in the active group and did not decline in the control group. Hydration of the upper airways appears promising as a non-drug approach for reducing risks of respiratory diseases such as COVID-19.
DOI: 10.1016/j.cell.2020.05.042
发表时间: 2020-07-23
期刊: CELL
影响因子: 64.5
作者:
Hou, Yixuan J.;Okuda, Kenichi;Baric, Ralph S.
通讯作者: Baric, Ralph S.
DOI: 10.1073/pnas.1902840116
发表时间: 2019-05-28
影响因子: 11.1
作者:
Kudo, Eriko;Song, Eric;Iwasaki, Akiko
通讯作者: Iwasaki, Akiko
DOI: 10.3389/fimmu.2021.752227
发表时间: 2021
影响因子: 7.3
作者:
Kumar S;Çalışkan DM;Janowski J;Faist A;Conrad BCG;Lange J;Ludwig S;Brunotte L
通讯作者: Brunotte L
十个科学原因支持SARS-COV-2的机载传播。
DOI: 10.1016/s0140-6736(21)00869-2
发表时间: 2021-05-01
期刊: Lancet (London, England)
影响因子: --
作者:
Greenhalgh T;Jimenez JL;Prather KA;Tufekci Z;Fisman D;Schooley R
通讯作者: Schooley R
DOI: 10.1017/jfm.2021.608
发表时间: 2021-08-23
影响因子: 3.7
作者:
Etzold, Merlin A.;Linden, P. F.;Worster, M. Grae
通讯作者: Worster, M. Grae